HOME
|
CONTACT
|
SITEMAP
HOME
CORPORATE
OUR COMPANY
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY
BOARD
CORPORATE GOVERNANCE
TECHNOLOGY
OUR PIPELINE
ABOUT CANCER STEM CELLS
THERAPEUTIC AREAS
INVESTORS
OUR BUSINESS AND
POSITIONING
STOCK INFORMATION
FINANCIAL REPORTS
INVESTOR
COMMUNICATIONS
SHAREHOLDER SERVICES
INVESTOR CONTACT
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
TSX - Venture:
SSS
PRESS RELEASES
EVENTS
PRESENTATIONS
PRESS RELEASES
Currently Viewing:
Latest Press Releases
Press releases from 2013
Press releases from 2012
Press releases from 2011
Press releases from 2010
Press releases from 2009
Press releases from 2008
Press releases from 2007
Press releases from 2006
Press releases from 2005
Press releases from 2004
May 16, 2013
Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome
May 16, 2013
Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace
Apr 17, 2013
Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
Apr 09, 2013
Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options
Mar 28, 2013
Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
Mar 15, 2013
Stem Cell Therapeutics Closes $3.1 Million Financing
Mar 12, 2013
Stem Cell Therapeutics Announces Filing of Prospectus Supplement for Proceeds up to $3.5 Million of Units
Mar 07, 2013
Stem Cell Therapeutics Announces Offering of up to $3.5 million of Units
Feb 19, 2013
Stem Cell Therapeutics Announces Joint-Venture Agreement with Renu Inc. and Nexgen Medical Systems, Inc
Feb 19, 2013
Stem Cell Therapeutics Announces Proposed Offering of Units
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade:
0.16
Change:
+10.34%
Volume:
0
Date:
5/22/2013
Time:
3:59pm
Note: Quotes are delayed. For informational purposes only.
©2004 - 2013 Stem Cell Therapeutics - All rights reserved
Home
|
Site Map
|
Terms Of Use
|
Contact Us